Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.

MLA

Sommer, Christine, et al. “Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.” The Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 5, Apr. 2023, pp. 1110–19. EBSCOhost, https://doi.org/10.1210/clinem/dgac699.

APA

Sommer, C., Vangberg, K. G., Moen, G.-H., Evans, D. M., Lee-Ødegård, S., Blom-Høgestøl, I. K., Sletner, L., Jenum, A. K., Drevon, C. A., Gulseth, H. L., & Birkeland, K. I. (2023). Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans. The Journal of Clinical Endocrinology and Metabolism, 108(5), 1110–1119. https://doi.org/10.1210/clinem/dgac699

Chicago

Sommer, Christine, Kjersti G Vangberg, Gunn-Helen Moen, David M Evans, Sindre Lee-Ødegård, Ingvild K Blom-Høgestøl, Line Sletner, et al. 2023. “Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.” The Journal of Clinical Endocrinology and Metabolism 108 (5): 1110–19. doi:10.1210/clinem/dgac699.